Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia, including infants whose cancer may be more likely to return after treatment.
Dr. Lisa Niswander
Advertisement
Articles by Dr. Lisa Niswander
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Finding the Words: How to Talk to Someone With Cancer
2
Getting Ready to Swim in a Sea of Pink
3
FDA Approves Bravnetsa, an Equivalent to Lutathera, for GEP-NETs
4
Cancer Research Is Looking Beyond the Tumor to Better Understand the Whole Patient
5